This inventor holds 1 USPTO granted patent. Top assignee: Universitè Catholique De Louvain. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Dominuque Latinne: Innovator in Immunology
Introduction
Dominuque Latinne is a prominent inventor based in Brussels, Belgium. He has made significant contributions to the field of immunology, particularly through his innovative research and development of antibodies.
Latest Patents
One of his notable patents is the LO-CD2a antibody, which is designed to inhibit T cell activation. This invention relates to methods of using the LO-CD2a antibody or similar molecules to prevent and inhibit immune responses in human patients. The administration of an effective amount of this antibody can prevent or inhibit graft rejection, graft versus host disease, or autoimmune diseases.
Career Highlights
Dominuque Latinne is affiliated with Université Catholique de Louvain, where he conducts his research and development work. His expertise in immunology has positioned him as a key figure in the advancement of therapeutic strategies aimed at modulating immune responses.
Collaborations
He collaborates with various professionals in his field, including his coworker, Herve Bazin. Their joint efforts contribute to the ongoing research and development of innovative solutions in immunology.
Conclusion
Dominuque Latinne's work, particularly with the LO-CD2a antibody, showcases his commitment to advancing medical science and improving patient outcomes. His contributions to immunology are invaluable and continue to influence the field significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile